| __timestamp | Neurocrine Biosciences, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 46425000 | 581800000 |
| Thursday, January 1, 2015 | 81491000 | 671900000 |
| Friday, January 1, 2016 | 94291000 | 876700000 |
| Sunday, January 1, 2017 | 121827000 | 857900000 |
| Monday, January 1, 2018 | 160524000 | 822200000 |
| Tuesday, January 1, 2019 | 200000000 | 778200000 |
| Wednesday, January 1, 2020 | 275000000 | 512600000 |
| Friday, January 1, 2021 | 328100000 | 681000000 |
| Saturday, January 1, 2022 | 463800000 | 662200000 |
| Sunday, January 1, 2023 | 565000000 | 910700000 |
| Monday, January 1, 2024 | 731100000 |
Unlocking the unknown
In the ever-evolving landscape of biopharmaceuticals, Research and Development (R&D) is the lifeblood of innovation. Over the past decade, Neurocrine Biosciences, Inc. and Viatris Inc. have demonstrated contrasting yet compelling R&D trajectories. Neurocrine Biosciences has seen a staggering 1,116% increase in R&D expenses from 2014 to 2023, reflecting its commitment to pioneering treatments. In contrast, Viatris Inc., while maintaining a robust R&D budget, has shown a more stable investment pattern, with a 57% increase over the same period. This divergence highlights the strategic differences between a rapidly growing biotech firm and a more established pharmaceutical giant. As we look to the future, these trends underscore the dynamic nature of the industry and the critical role of R&D in driving medical breakthroughs.
Comparing Innovation Spending: Amgen Inc. and Neurocrine Biosciences, Inc.
Comparing Innovation Spending: Neurocrine Biosciences, Inc. and Alkermes plc
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Neurocrine Biosciences, Inc. and CRISPR Therapeutics AG Allocate Funds
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Neurocrine Biosciences, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?